Lessons in global health from the pharma bad boy

If pharmaceutical companies had a human face, it would probably be that of Martin Shkreli, former chief executive of Turing Pharmaceuticals who notoriously increased the price of life-saving drug Daraprim (pyrimethamine) by more than 50-fold in the US. Pyrimethamine is an essential antiparasitic drug listed in the World Health Organization